IBDEI149 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17925,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,17925,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,17926,0)
 ;;=G20.^^88^899^25
 ;;^UTILITY(U,$J,358.3,17926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17926,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,17926,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,17926,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,17927,0)
 ;;=G31.01^^88^899^26
 ;;^UTILITY(U,$J,358.3,17927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17927,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,17927,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,17927,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,17928,0)
 ;;=G23.1^^88^899^28
 ;;^UTILITY(U,$J,358.3,17928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17928,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,17928,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,17928,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,17929,0)
 ;;=Z79.2^^88^900^1
 ;;^UTILITY(U,$J,358.3,17929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17929,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,17929,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,17929,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,17930,0)
 ;;=Z79.01^^88^900^2
 ;;^UTILITY(U,$J,358.3,17930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17930,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,17930,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,17930,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,17931,0)
 ;;=Z79.02^^88^900^3
 ;;^UTILITY(U,$J,358.3,17931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17931,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,17931,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,17931,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,17932,0)
 ;;=Z79.82^^88^900^4
 ;;^UTILITY(U,$J,358.3,17932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17932,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,17932,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,17932,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,17933,0)
 ;;=Z79.4^^88^900^6
 ;;^UTILITY(U,$J,358.3,17933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17933,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,17933,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,17933,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,17934,0)
 ;;=Z79.1^^88^900^9
 ;;^UTILITY(U,$J,358.3,17934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17934,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,17934,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,17934,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,17935,0)
 ;;=Z79.891^^88^900^8
 ;;^UTILITY(U,$J,358.3,17935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17935,1,3,0)
 ;;=3^Long Term Opiate/Opioid Analgesic Use
 ;;^UTILITY(U,$J,358.3,17935,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,17935,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,17936,0)
 ;;=Z79.51^^88^900^5
 ;;^UTILITY(U,$J,358.3,17936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17936,1,3,0)
 ;;=3^Inhaled Steroids
 ;;^UTILITY(U,$J,358.3,17936,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,17936,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,17937,0)
 ;;=Z79.52^^88^900^11
 ;;^UTILITY(U,$J,358.3,17937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17937,1,3,0)
 ;;=3^Steroids-Systemic
 ;;^UTILITY(U,$J,358.3,17937,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,17937,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,17938,0)
 ;;=Z79.899^^88^900^7
 ;;^UTILITY(U,$J,358.3,17938,1,0)
 ;;=^358.31IA^4^2
